American Journal of Roentgenology, Vol 166, 531-536, Copyright © 1996 by American Roentgen Ray Society

ARTICLES

Differentiation of adrenal adenomas from nonadenomas using CT attenuation values

M Korobkin, FJ Brodeur, GG Yutzy, IR Francis, LE Quint, NR Dunnick and EA Kazerooni
Department of Radiology, University of Michigan Medical Center, Ann Arbor, 48109-0030, USA.

OBJECTIVE: The purpose of our study was to determine whether unenhanced CT attenuation value, enhanced CT attenuation value, or lesion size can be used to differentiate adrenal adenomas from nonadenomatous adrenal masses. MATERIALS AND METHODS: We retrospectively assessed the CT scans of 135 adrenal masses in 124 patients with a variety of adrenal masses. There were 93 cortical adenomas (85 nonhyperfunctioning adenomas, four Cushing's adenomas, and four primary aldosteronism adenomas). The nonadenomas consisted of 34 metastases, four cortical carcinomas, and four pheochromocytomas. The scattergrams and mean values of the size and attenuation values on enhanced and unenhanced scans were correlated with the final diagnoses. Results were also subjected to receiver operating characteristic analysis. RESULTS: Forty-one adenomas and 20 nonadenomas had unenhanced CT. The mean attenuation value of the 41 adenomas was significantly lower (p < .001) than that of the nonadenomas (2.5 H +/- 14 compared with 32 H +/- 6.4). The lowest unenhanced CT attenuation value of the nonadenomas was 18 H; therefore, the sensitivity:specificity ratio for the diagnosis of adenomas was 85%:100% at a threshold value of 18 H. At this threshold, the positive predictive value was 100% and the negative predictive value was 77%. For the 85 masses with enhanced CT, the mean attenuation of the 60 adenomas was also significantly lower (p < .01) than for the 25 nonadenomas (47 H +/- 24 compared with 62 H +/- 21). The lowest enhanced CT attenuation value of the nonadenomas was also 18 H, but the sensitivity:specificity ratio was only 10%:100% at this threshold value of 18 H. Although the mean diameter of the adenomas was significantly lower (p < .001) than for the nonadenomas (2.4 cm +/- 0.9 compared with 4.5 cm +/- 2.5), there was sufficient overlap between the two groups at the smallest sizes that a threshold value for a highly specific diagnosis of adenoma was not present. The area under the receiver operating characteristic curve for unenhanced CT attenuation values (0.98 +/- 0.02) was significantly greater than the area for enhanced CT values (0.68 +/- 0.06, p < .001) and the area for size (0.79 +/- 0.04, p < .001). CONCLUSIONS: Unenhanced CT attenuation values can characterize an adrenal mass as a benign adenoma with high specificity and acceptable sensitivity. Adrenal masses cannot be characterized using enhanced CT attenuation values or lesion size.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. M. Ho, E. K. Paulson, M. J. Brady, T. Z. Wong, and S. T. Schindera Lipid-Poor Adenomas on Unenhanced CT: Does Histogram Analysis Increase Sensitivity Compared with a Mean Attenuation Threshold? Am. J. Roentgenol., July 1, 2008; 191(1): 234 - 238. [Abstract] [Full Text] [PDF]

				J. H. Song, F. S. Chaudhry, and W. W. Mayo-Smith The Incidental Adrenal Mass on CT: Prevalence of Adrenal Disease in 1,049 Consecutive Adrenal Masses in Patients with No Known Malignancy Am. J. Roentgenol., May 1, 2008; 190(5): 1163 - 1168. [Abstract] [Full Text] [PDF]

				J. H. Song, F. S. Chaudhry, and W. W. Mayo-Smith The Incidental Indeterminate Adrenal Mass on CT (> 10 H) in Patients Without Cancer: Is Further Imaging Necessary? Follow-Up of 321 Consecutive Indeterminate Adrenal Masses Am. J. Roentgenol., November 1, 2007; 189(5): 1119 - 1123. [Abstract] [Full Text] [PDF]

				M Brookes, D MacVicar, and J Husband Metastatic carcinoma of the breast: the appearances of metastatic spread to the abdomen and pelvis as demonstrated by CT Br. J. Radiol., April 1, 2007; 80(952): 284 - 292. [Abstract] [Full Text] [PDF]

				G. C. Mackie, B. L. Shulkin, R. C. Ribeiro, F. P. Worden, P. G. Gauger, R. J. Mody, L. P. Connolly, G. Kunter, C. Rodriguez-Galindo, J. W. Wallis, et al. Use of [18F]Fluorodeoxyglucose Positron Emission Tomography in Evaluating Locally Recurrent and Metastatic Adrenocortical Carcinoma J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2665 - 2671. [Abstract] [Full Text] [PDF]

				G. Savci, Z. Yazici, N. Sahin, S. Akgoz, and E. Tuncel Value of Chemical Shift Subtraction MRI in Characterization of Adrenal Masses Am. J. Roentgenol., January 1, 2006; 186(1): 130 - 135. [Abstract] [Full Text] [PDF]

				M. A. Blake, M. K. Kalra, A. T. Sweeney, B. C. Lucey, M. M. Maher, D. V. Sahani, E. F. Halpern, P. R. Mueller, P. F. Hahn, and G. W. Boland Distinguishing Benign from Malignant Adrenal Masses: Multi-Detector Row CT Protocol with 10-Minute Delay Radiology, December 21, 2005; (2005) 2382041514. [Abstract] [Full Text]

				A. H. Hamrahian, A. G. Ioachimescu, E. M. Remer, G. Motta-Ramirez, H. Bogabathina, H. S. Levin, S. Reddy, I. S. Gill, A. Siperstein, and E. L. Bravo Clinical Utility of Noncontrast Computed Tomography Attenuation Value (Hounsfield Units) to Differentiate Adrenal Adenomas/Hyperplasias from Nonadenomas: Cleveland Clinic Experience J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 871 - 877. [Abstract] [Full Text] [PDF]

				D. H. Szolar, M. Korobkin, P. Reittner, A. Berghold, T. Bauernhofer, H. Trummer, H. Schoellnast, K. W. Preidler, and H. Samonigg Adrenocortical Carcinomas and Adrenal Pheochromocytomas: Mass and Enhancement Loss Evaluation at Delayed Contrast-enhanced CT Radiology, February 1, 2005; 234(2): 479 - 485. [Abstract] [Full Text] [PDF]

				J. M. Pereira, C. B. Sirlin, P. S. Pinto, and G. Casola CT and MR Imaging of Extrahepatic Fatty Masses of the Abdomen and Pelvis: Techniques, Diagnosis, Differential Diagnosis, and Pitfalls RadioGraphics, January 1, 2005; 25(1): 69 - 85. [Abstract] [Full Text] [PDF]

				R. Kumar, Y. Xiu, J. Q. Yu, A. Takalkar, G. El-Haddad, S. Potenta, J. Kung, H. Zhuang, and A. Alavi 18F-FDG PET in Evaluation of Adrenal Lesions in Patients with Lung Cancer J. Nucl. Med., December 1, 2004; 45(12): 2058 - 2062. [Abstract] [Full Text] [PDF]

				K. Pacak, G. Eisenhofer, and D. S. Goldstein Functional Imaging of Endocrine Tumors: Role of Positron Emission Tomography Endocr. Rev., August 1, 2004; 25(4): 568 - 580. [Abstract] [Full Text] [PDF]

				G. M. Israel, M. Korobkin, C. Wang, E. N. Hecht, and G. A. Krinsky Comparison of Unenhanced CT and Chemical Shift MRI in Evaluating Lipid-Rich Adrenal Adenomas Am. J. Roentgenol., July 1, 2004; 183(1): 215 - 219. [Abstract] [Full Text] [PDF]

				M. A. Haider, S. Ghai, K. Jhaveri, and G. Lockwood Chemical Shift MR Imaging of Hyperattenuating (>10 HU) Adrenal Masses: Does It Still Have a Role? Radiology, June 1, 2004; 231(3): 711 - 716. [Abstract] [Full Text] [PDF]

				G. Mansmann, J. Lau, E. Balk, M. Rothberg, Y. Miyachi, and S. R. Bornstein The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management Endocr. Rev., April 1, 2004; 25(2): 309 - 340. [Abstract] [Full Text] [PDF]

				P. H. Kann, B. Wirkus, T. Behr, K.-J. Klose, and S. Meyer Endosonographic Imaging of Benign and Malignant Pheochromocytomas J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1694 - 1697. [Abstract] [Full Text] [PDF]

				P. M. Copeland Management of the Clinically Inapparent Adrenal Mass Ann Intern Med, March 2, 2004; 140(5): 401 - 401. [Full Text] [PDF]

				M. Hellstrom, M. H. Svensson, and A. Lasson Extracolonic and Incidental Findings on CT Colonography (Virtual Colonoscopy) Am. J. Roentgenol., March 1, 2004; 182(3): 631 - 638. [Abstract] [Full Text] [PDF]

				A. Stadler, W. Schima, G. Prager, P. Homolka, G. Heinz, S. Saini, E. Eisenhuber, and B. Niederle CT Density Measurements for Characterization of Adrenal Tumors Ex Vivo: Variability Among Three CT Scanners Am. J. Roentgenol., March 1, 2004; 182(3): 671 - 675. [Abstract] [Full Text] [PDF]

				A. G. Rockall, S. A. Babar, S. A. A. Sohaib, A. M. Isidori, S. Diaz-Cano, J. P. Monson, A. B. Grossman, and R. H. Reznek CT and MR Imaging of the Adrenal Glands in ACTH-independent Cushing Syndrome RadioGraphics, March 1, 2004; 24(2): 435 - 452. [Abstract] [Full Text] [PDF]

				I. Ilias and K. Pacak Current Approaches and Recommended Algorithm for the Diagnostic Localization of Pheochromocytoma J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 479 - 491. [Full Text] [PDF]

				M. A. Blake, S. K. Krishnamoorthy, G. W. Boland, A. T. Sweeney, M. B. Pitman, M. Harisinghani, P. R. Mueller, and P. F. Hahn Low-Density Pheochromocytoma on CT: A Mimicker of Adrenal Adenoma Am. J. Roentgenol., December 1, 2003; 181(6): 1663 - 1668. [Abstract] [Full Text] [PDF]

				H. J. Zeh III and R. Udelsman One Hundred Laparoscopic Adrenalectomies: A Single Surgeon's Experience Ann. Surg. Oncol., November 1, 2003; 10(9): 1012 - 1017. [Abstract] [Full Text] [PDF]

				M. E. Hurley, B. R. Herts, E. M. Remer, D. Dylinski, and I. S. Gill Three-dimensional Volume-rendered Helical CT before Laparoscopic Adrenalectomy Radiology, November 1, 2003; 229(2): 581 - 586. [Abstract] [Full Text] [PDF]

				K. T. Bae, P. Fuangtharnthip, S. R. Prasad, B. N. Joe, and J. P. Heiken Adrenal Masses: CT Characterization with Histogram Analysis Method Radiology, September 1, 2003; 228(3): 735 - 742. [Abstract] [Full Text] [PDF]

				N. R. Dunnick Answer Am. J. Roentgenol., November 1, 2002; 179 (5): 1344 - 1344. [Full Text] [PDF]

				N. R. Dunnick and M. Korobkin Imaging of Adrenal Incidentalomas: Current Status Am. J. Roentgenol., September 1, 2002; 179(3): 559 - 568. [Full Text] [PDF]

				M. Terzolo, A. Pia, A. Ali, G. Osella, G. Reimondo, S. Bovio, F. Daffara, M. Procopio, P. Paccotti, G. Borretta, et al. Adrenal Incidentaloma: A New Cause of the Metabolic Syndrome? J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 998 - 1003. [Abstract] [Full Text] [PDF]

				J.A. Verschakelen, J. Bogaert, and W. De Wever Computed tomography in staging for lung cancer Eur. Respir. J., February 1, 2002; 19(35_suppl): 40S - 48s. [Abstract] [Full Text] [PDF]

				W. W. Mayo-Smith, G. W. Boland, R. B. Noto, and M. J. Lee State-of-the-Art Adrenal Imaging RadioGraphics, July 1, 2001; 21(4): 995 - 1012. [Abstract] [Full Text] [PDF]

				G. Osella, G. Reimondo, P. Peretti, A. Alì, P. Paccotti, A. Angeli, and M. Terzolo The Patients with Incidentally Discovered Adrenal Adenoma (Incidentaloma) Are Not at Increased Risk of Osteoporosis J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 604 - 607. [Abstract] [Full Text]

				M. Korobkin CT Characterization of Adrenal Masses: The Time Has Come Radiology, December 1, 2000; 217(3): 629 - 632. [Full Text]

				C. S. Peña, G. W. L. Boland, P. F. Hahn, M. J. Lee, and P. R. Mueller Characterization of Indeterminate (Lipid-poor) Adrenal Masses: Use of Washout Characteristics at Contrast-enhanced CT Radiology, December 1, 2000; 217(3): 798 - 802. [Abstract] [Full Text]

				E. M. Caoili, M. Korobkin, I. R. Francis, R. H. Cohan, and N. R. Dunnick Delayed Enhanced CT of Lipid-Poor Adrenal Adenomas Am. J. Roentgenol., November 1, 2000; 175(5): 1411 - 1415. [Abstract] [Full Text] [PDF]

				E. M. Remer, N. Obuchowski, J. D. Ellis, T. W. Rice, D. J. Adelstein, and M. E. Baker Adrenal Mass Evaluation in Patients with Lung Carcinoma: A Cost-Effectiveness Analysis Am. J. Roentgenol., April 1, 2000; 174(4): 1033 - 1039. [Abstract] [Full Text] [PDF]

				M. Terzolo, S. Bossoni, A. Alí, M. Doga, G. Reimondo, G. Milani, P. Peretti, F. Manelli, A. Angeli, and A. Giustina Growth Hormone (GH) Responses to GH-Releasing Hormone Alone or Combined with Arginine in Patients with Adrenal Incidentaloma: Evidence for Enhanced Somatostatinergic Tone J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1310 - 1315. [Abstract] [Full Text]

				S. A. Sohaib, P. D. Peppercorn, C. Allan, J. P. Monson, A. B. Grossman, G. M. Besser, and R. H. Reznek Primary Hyperaldosteronism (Conn Syndrome): MR Imaging Findings Radiology, February 1, 2000; 214(2): 527 - 531. [Abstract] [Full Text]

				E. M. Marom, H. P. McAdams, J. J. Erasmus, P. C. Goodman, D. K. Culhane, R. E. Coleman, J. E. Herndon, and E. F. Patz Jr Staging Non-Small Cell Lung Cancer with Whole-Body PET Radiology, September 1, 1999; 212(3): 803 - 809. [Abstract] [Full Text]

				E. F. Patz Jr, J. J. Erasmus, H. P. McAdams, J. E. Connolly, E. M. Marom, P. C. Goodman, R. A. Leder, M. T. Keogan, and J. E. Herndon Lung Cancer Staging and Management: Comparison of Contrast-enhanced and Nonenhanced Helical CT of the Thorax Radiology, July 1, 1999; 212(1): 56 - 60. [Abstract] [Full Text]

				G. A. Agrons, G. J. Lonergan, G. E. Dickey, and J. E. Perez-Monte From the Archives of the AFIP: Adrenocortical Neoplasms in Children: Radiologic-Pathologic Correlation RadioGraphics, July 1, 1999; 19(4): 989 - 1008. [Abstract] [Full Text] [PDF]

				H. L. Porte, O. J. Ernst, T. Delebecq, D. Metois, L. G. Lemaitre, and A. J. Wurtz Is computed tomography guided biopsy still necessary for the diagnosis of adrenal masses in patients with resectable non-small-cell lung cancer? Eur. J. Cardiothorac. Surg., May 1, 1999; 15(5): 597 - 601. [Abstract] [Full Text] [PDF]

				R. N. Low, R. C. Semelka, S. Worawattanakul, G. D. Alzate, and J. S. Sigeti Extrahepatic Abdominal Imaging in Patients with Malignancy: Comparison of MR Imaging and Helical CT, with Subsequent Surgical Correlation Radiology, March 1, 1999; 210(3): 625 - 632. [Abstract] [Full Text]

				V. J Lowe and K. S Naunheim Current role of positron emission tomography in thoracic oncology Thorax, August 1, 1998; 53(8): 703 - 712. [Full Text]

				E. M. Caoili, M. Korobkin, I. R. Francis, R. H. Cohan, J. F. Platt, N. R. Dunnick, and K. I. Raghupathi Adrenal Masses: Characterization with Combined Unenhanced and Delayed Enhanced CT Radiology, March 1, 2002; 222(3): 629 - 633. [Abstract] [Full Text] [PDF]